WAY-620147
WAY-620147 (compound 6) is an N- (2-morpholinoethyl) nicotinamide derivative that inhibits monoamine oxidase (Monoamine Oxidase) . WAY-620147 inhibits MAO-A and MAO-B with IC50s of 26 μM and 55 μM, respectively[1].
Product Specifications
CAS Number
515866-67-8
UNSPSC
12352005
Hazard Statement
H315-H319-H320
Target
Monoamine Oxidase
Type
Reference compound
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/way-620147.html
Purity
98.0
Solubility
DMSO : ≥ 100 mg/mL
Smiles
C1COCCN1CCNC(=O)C2=CC(=CN=C2)Br
Molecular Formula
C12H16BrN3O2
Molecular Weight
314.18
Precautions
P264-P280-P302+P352-P305+P351+P338-P362
References & Citations
[1]Shi L, et al. Design of novel nicotinamides as potent and selective monoamine oxidase a inhibitors. Bioorg Med Chem. 2010 Feb 15;18 (4) :1659-64.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
1,2,3,4,6-Penta-O-galloyl-Beta-D-glucopyranose >90%
Recombinant Human CD300a/LMIR1 Protein (His Tag)